ATR and Miyoshi myopathy: Likewise, MM cells lines bearing TP53 mutation showed better response to ATR inhibition compared to TP53 wild-type MM cell lines, implying that, in the subset of MM clones with increased replicative stress, and DNA damage, inhibition of ATR could be potentially exploited as a synthetic lethal therapeutic approach (75).